Division of @LiminalBio working to create plasma-based therapeutic products. See our social media community guidelines at https://xitter.cf/t.co/fXTBPk4BTa

Joined October 2020
Prometic BioProduction & BioTherapeutics retweeted
“The execution of the Share Purchase Agreement is a key step in our strategy to refocus our resources on the development of our small molecule pipeline”, said Bruce Pritchard, CEO of Liminal BioSciences. Read more: loom.ly/xKRE5OI
15
1
1